�鶹Ů��

The Food and Drug Administration on Tuesday approved Novo Nordisk’s Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular injection in the U.S. (Constantino, 1/28)

A coalition of around 20,000 advocates and twelve major health care groups has called on the Centers for Medicare & Medicaid Services (CMS) to expand Medicare and Medicaid to include FDA-approved anti-obesity medications. The letters are being led by the Health Equity Coalition for Chronic Disease (HECCD) and they say the change would potentially benefit up to 7.5 million Americans enrolled in these federal programs who are living with obesity, per the press release. (Dickey, 1/28)

The University of Chicago is partnering with a health care investment firm that has pledged up to $130 million to help turn the school’s research and discoveries into medications more quickly. The university and Deerfield Management are partnering on the initiative, called Hyde Park Discovery. Deerfield will spend up to $130 million over the next 10 years, and offer its expertise to help advance the university’s discoveries, in hopes of bringing them to the health care market. (Schencker, 1/28)

The Super Bowl ad for weight loss medications from direct-to-consumer telehealth company Hims & Hers released Tuesday is optimized to engage and infuriate. Over the refrain of Childish Gambino’s anti-racist anthem “This Is America,” its narrator makes the case that the weight loss industry, including drugmakers, are extracting profits from overweight and obese Americans without really helping them. (Palmer, 1/28)